-
Product Insights
Charcot-Marie-Tooth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Charcot-Marie-Tooth Disease Type I A – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Charcot-Marie-Tooth Disease Type II – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type II - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type II pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type II, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Charcot-Marie-Tooth Disease Type I – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type I pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...